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果表明约氏疟原虫来源的 U6 snRNA 启动子在伯氏疟原虫中特异驱动





























Malaria, transmitted by Anopheles mosquitoes, is an infectious disease caused by 
five Plasmodium parasites. Approximately 0.58 million of people died from the 
disease in 2013, and it remains a heavy burden on public health in many parts of the 
world. The most susceptible and vulnerable populations are children under 5 years old 
in Sub-Saharan Africa countries. There are also several species of rodent malaria 
parasites that are valuable models for studying parasite-host interactions. Among them, 
Plasmodium berghei ANKA produces the experimental cerebral malaria (ECM) 
symptoms in mice and has been widely used as an animal model for studying 
pathogenic mechanism of the human malaria parasite P. falciparum infection. 
Although various techniques for transfecting malaria parasites have been developed, 
genetic manipulation of malaria parasite remains inefficient.  
CRISPR/Cas systems are adaptable immune mechanisms used by many archaea 
and bacteria to protect themselves from foreign nucleic acids, such as viruses or 
plasmids. Recently, the CRISPR/Cas9 platform has been adopted to efficiently modify 
genomes of various organisms and cells. Before this study, however, there has been no 
report of using the CRISPR/Cas9 to modify P.berghei genome. 
This study demonstrates that sgRNA/Cas9 complex can introduce site-speciﬁc 
DNA double-strand breaks in the P. berghei genome that can be repaired through 
homologous recombination pathway. We first showed that P. yoelii U6 small nuclear 
RNA (snRNA) promoter could drive the sgRNA transcription, and that the “2A” 
peptide could be sued to drive dual protein (hDHFR and SpCas9 proteins) synthesis in 
P. berghei. By supplying templates homologous repair, we generated targeted gene 
knockout, short tag knockin, and nucleotide allelic replacement in different parasite 
genes. Specifically, we knockouted a gene encoding P. berghei macrophage migration 
inhibitory factor (Pbmif), tagged the gene with Myc×3, and replaced specific 
nucleotides in the gene successfully. We also disrupted the Pbap2-g gene 


















showed that Pbap2-g knockout parasite could not produce gametocytes or oocysts in 
the mosquito stage. 
In conclusion, we successfully established a methodology that can be used to 
achieve desired modiﬁcations in the P. berghei genome with high efﬁciency and 
accuracy, which will greatly improve our ability to study the gene function of the 
parasite. 
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图 1-1  2013 年全球不同国家的疟疾流行分布图（不同颜色代表每 1000个人中感染疟
疾人数的多少）。 
Fig. 1-1 Countries with ongoing transmission of malaria, 2013(different colors represent the 









































































































图 1-2 疟原虫生活史简图。 





时间约 8~9天（休眠子可达数年之久），恶性疟原虫 6~7天，三日疟原虫 11~12
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